Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @TAGTeam_Tweets
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @TAGTeam_Tweets
-
TAG Team proslijedio/la je Tweet
#CSOs spanning the world have expressed concerns about proposed changes to non-State Actors' involvement with@WHO governing bodies. They call on@DrTedros at#EB146 to consult with NSAs before or at#WHA73. Read the full letter: http://haiweb.org/media-resource/non-state-actors/ …#MedsinEUpic.twitter.com/fC3vFPOLzM
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TAG Team proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Injectable meds 4 drug-resistant
#TB are officially out!

@WHO recommends all-oral regimens ranging 6–20 mo. for#MDRTB +#XDRTB#ItsTime for countries to act: ensure access to#bedaquiline + invest in lab capacity + active drug safety monitoring: https://www.who.int/tb/publications/2018/rapid_communications_MDR/en/ …pic.twitter.com/7G8YKfPf6O
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TAG Team proslijedio/la je Tweet
Thanks to £24m of
@Unitaid funding,#Liverpool is set to lead a new research project to develop long-acting medicines that could transform the way the world prevents & treats#TB#HepC and#malaria. Full story here
http://bit.ly/2ObVgas pic.twitter.com/lRCgR2sajD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're proud to be part of this project to develop long-acting
#TB +#HCV meds that meet communities' needs. Looking forward to getting input from all of you + sharing updates@EATGx@ITPCglobal@NO_hep@G_C_T_A@TBECoalition@TBProof@hepCoalition@CHAI_health@TAChttps://twitter.com/UNITAID/status/1222914341328039936 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Did you miss our
#webinar on how to prioritize#HIV#coinfections and#AIDS in#PEPFAR planning for 2020? The webinar recording and presentations are online now: https://www.treatmentactiongroup.org/webinar/good-cops-or-bad-cops-promoting-interventions-for-coinfections-and-aids-in-2020-pepfar-country-operational-plans-cops/ …#TB#HCVpic.twitter.com/ntlbQcLX4m
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Addressing the problems created by current U.S. immigration policy requires our movements to effectively mobilize communities + reject flawed media framing. “This is Not A Drill” from our November TAGline shows how we can act in
#solidarityhttp://treatmentactiongroup.org/taglineHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wondering about the latest updates on recent
#TB#vaccine candidate M72/AS01E?
We'll give you the latest at our #webinar with@HIVpxresearch, "What's New—and Next—for#TB#Vaccines" on Feb 6 @ 9 AM EST. Register here:https://zoom.us/webinar/register/WN_dhS5qJT4S9Omi8wMnn2Yew …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We strongly opposes the Supreme Court's majority decision to lift an injunction on the Trump administration's
#PublicCharge rule: https://www.treatmentactiongroup.org/statement/treatment-action-group-joins-collective-call-denouncing-the-trump-administrations-dangerous-finalized-anti-immigrant-rule/ …pic.twitter.com/9HriddGKhS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
After patent oppositions in India & Thailand, Sanofi is feeling the heat!


Check out our statement on their withdrawn applications to patent #TB prevention drugs#rifapentine +#isoniazid in Europe + Indonesia:https://www.treatmentactiongroup.org/statement/sanofi-withdraws-two-patent-applications-on-life-saving-tuberculosis-prevention-drugs-in-europe-and-in-indonesia/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TAG Team proslijedio/la je Tweet
The Supreme Court's decision to uphold Trump's anti-immigrant, classist "public charge" rule is an affront on the American dream. We're gravely disappointed to see our justice system fail to protect immigrants, in New York and across the country.https://www.cbsnews.com/news/supreme-court-greenlights-trumps-public-charge-rule-to-restrict-legal-immigration/ …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2018’s UN HLM set an ambitious goal to reach $2 billion in
#TB research funding. Our latest TB R&D report shows what sectors spending increased in (public sector) and where funding is flat (private sector): https://www.treatmentactiongroup.org/resources/tbrd-report/tbrd-report-2019/ …pic.twitter.com/xVUhHBgDOe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TAG Team proslijedio/la je Tweet
#HepC tests & generic cure can cost $80/person. Yet not case for most countries. So many health systems barriers prevent people from knowing their#HCV status; cost to test-and-treat should NOT be one of them! Check out new#mapCrowd brief: http://tinyurl.com/t29pgk9#InvestinHepCpic.twitter.com/i3l1unSEH0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TAG Team proslijedio/la je Tweet
Are you from a TB-affected community and want to get more involved in TB research??? TB Community Advisory Board (TB-CAB) has a call for applications. Great opportunity to input into TB R&D and Access issues. https://bit.ly/37kCNQy .
@TAGTeam_Tweets .@TheUnion_TBLHHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Last year,
@NYGovCuomo cut $65 million in#NYC health programs for communities + families.@AndreaSCousins &@CarlHeastie must work with@DickGottfried &@NYSenatorRivera@NYCMayor@NYCCouncil@NYCSpeakerCoJo@MarkLevine to restore Article 6 funding!#GoBoldonHealthcarepic.twitter.com/rXafzNrETz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today,
@JnJNews released quarterly earnings of over $82 BILLION, profiting off the backs of#TB patients + public research investments. We joined@MSF_access@NYSE to demand@JnJNews drop#bedaquiline price to $1/day!#NoMoreTears@JNJGlobalHealthpic.twitter.com/qsBruiqJJs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TAG Team proslijedio/la je Tweet

@JNJCares didn’t develop TB drug bedaquiline alone, and should NOT alone be deciding who can and can’t get access. That's why we're outside@NYSE to demand that@JNJGlobalHealth drop the price to $1/day.#NoMoreTears
http://ow.ly/dAVI50y25rV pic.twitter.com/uoTAOcdZ0QHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TAG Team proslijedio/la je Tweet
LIVE: @MSF is outside@NYSE to demand@JNJCares lower the price of lifesaving TB drug bedaquiline following their US$82.1 BILLION sales announcement#NoMoreTears@JNJGlobalHealth http://ow.ly/dAVI50y25rV https://www.facebook.com/watch/live/?v=777110449463181¬if_id=1579707688884616¬if_t=live_video_explicit …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ICYMI: The Jan 17 version of our free online resource, "
#Research Toward an#HIV#Cure Clinical Trials," is up on our site: http://www.treatmentactiongroup.org/cure/trials#Science#Vaccinespic.twitter.com/DUgASeUDE0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
All countries, including France, should support global resolution on drug pricing transparency. Publicly funded meds like
#TB's bedaquiline should remain as public goods, not locked under patent & premium prices: https://blogs.mediapart.fr/edition/transparence-dans-les-politiques-du-medicament/article/160120/novartis-scandal-product-system-encouraged-lack-publi …@londeixp@OTMedsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.